680 related articles for article (PubMed ID: 28634671)
1. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
2. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-Lymphocyte Ratio is a Predictor of Venous Thromboembolism in Gastric Cancer Patients.
Du P
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115236
[TBL] [Abstract][Full Text] [Related]
6. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
Grilz E; Posch F; Königsbrügge O; Schwarzinger I; Lang IM; Marosi C; Pabinger I; Ay C
Thromb Haemost; 2018 Nov; 118(11):1875-1884. PubMed ID: 30296815
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
[TBL] [Abstract][Full Text] [Related]
8. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer.
Lee KW; Bang SM; Kim S; Lee HJ; Shin DY; Koh Y; Lee YG; Cha Y; Kim YJ; Kim JH; Park DJ; Kim HH; Oh D; Lee JS
J Thromb Haemost; 2010 Mar; 8(3):540-7. PubMed ID: 20040044
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
10. Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis.
Salazar Adum JP; Diaz Quintero L; Fuentes HE; Lind BB; Caprini JA; Tafur AJ
Int Angiol; 2017 Dec; 36(6):553-557. PubMed ID: 28541021
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.
Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB
Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475
[TBL] [Abstract][Full Text] [Related]
12. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
Yang W; Liu Y
Thromb Res; 2015 Aug; 136(2):212-5. PubMed ID: 25533129
[TBL] [Abstract][Full Text] [Related]
13. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
[TBL] [Abstract][Full Text] [Related]
14. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
[TBL] [Abstract][Full Text] [Related]
17. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
18. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.
Kourelis TV; Wysokinska EM; Wang Y; Yang P; Mansfield AS; Tafur AJ
Lung Cancer; 2014 Dec; 86(3):358-62. PubMed ID: 25453848
[TBL] [Abstract][Full Text] [Related]
19. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
Yu L; Lv CY; Yuan AH; Chen W; Wu AW
World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
